AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
Authors
Keywords
-
Journal
GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-27
DOI
10.1038/s41434-019-0085-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in therapy for spinal muscular atrophy: promises and challenges
- (2018) Ewout J. N. Groen et al. Nature Reviews Neurology
- Plastin 3 Promotes Motor Neuron Axonal Growth and Extends Survival in a Mouse Model of Spinal Muscular Atrophy
- (2018) Aziza Alrafiah et al. Molecular Therapy-Methods & Clinical Development
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy
- (2017) N N Singh et al. GENE THERAPY
- A brief account of viral vectors and their promise for gene therapy
- (2017) M Finer et al. GENE THERAPY
- FDA-Approved Oligonucleotide Therapies in 2017
- (2017) Cy A. Stein et al. MOLECULAR THERAPY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac pathology in spinal muscular atrophy: a systematic review
- (2017) C. A. Wijngaarde et al. Orphanet Journal of Rare Diseases
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- PTEN Depletion Decreases Disease Severity and Modestly Prolongs Survival in a Mouse Model of Spinal Muscular Atrophy
- (2015) Daniel Little et al. MOLECULAR THERAPY
- Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose–response Study in Mice and Nonhuman Primates
- (2015) Kathrin Meyer et al. MOLECULAR THERAPY
- Spinal muscular atrophy—recent therapeutic advances for an old challenge
- (2015) Irene Faravelli et al. Nature Reviews Neurology
- Spinal Muscular Atrophy
- (2015) Stephen J. Kolb et al. NEUROLOGIC CLINICS
- Progresses towards safe and efficient gene therapy vectors
- (2015) Sergiu Chira et al. Oncotarget
- SMN1andSMN2copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR
- (2015) Deborah L. Stabley et al. Molecular Genetics & Genomic Medicine
- Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy
- (2014) Jonathan J. Cherry et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Gene Therapy: A Promising Approach to Treating Spinal Muscular Atrophy
- (2014) Pádraig J. Mulcahy et al. HUMAN GENE THERAPY
- Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation
- (2014) Shingo Kariya et al. JOURNAL OF CLINICAL INVESTIGATION
- Observational study of spinal muscular atrophy type I and implications for clinical trials
- (2014) R. S. Finkel et al. NEUROLOGY
- Skeletal Muscle DNA Damage Precedes Spinal Motor Neuron DNA Damage in a Mouse Model of Spinal Muscular Atrophy (SMA)
- (2014) Saniya Fayzullina et al. PLoS One
- SMN control of RNP assembly: From post-transcriptional gene regulation to motor neuron disease
- (2014) Darrick K. Li et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials
- (2013) Chiara Zanetta et al. CLINICAL THERAPEUTICS
- At the “Junction” of Spinal Muscular Atrophy Pathogenesis: The Role of Neuromuscular Junction Dysfunction in SMA Disease Progression
- (2013) B. Goulet et al. CURRENT MOLECULAR MEDICINE
- Adeno-associated virus structural biology as a tool in vector development
- (2013) Lauren M Drouin et al. Future Virology
- Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?
- (2013) Monir Shababi et al. JOURNAL OF ANATOMY
- Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA
- (2013) Sarah L. DeVos et al. Neurotherapeutics
- Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro
- (2013) A Garcera et al. Cell Death & Disease
- Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy
- (2013) Justin G Boyer et al. Skeletal Muscle
- Survival Motor Neuron Protein in Motor Neurons Determines Synaptic Integrity in Spinal Muscular Atrophy
- (2012) T. L. Martinez et al. JOURNAL OF NEUROSCIENCE
- Europe gives gene therapy the green light
- (2012) Karl Gruber LANCET
- Spinal muscular atrophy: going beyond the motor neuron
- (2012) Gillian Hamilton et al. TRENDS IN MOLECULAR MEDICINE
- Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques
- (2012) Benjamin Dehay et al. Scientific Reports
- Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy
- (2011) M. A. Farrar et al. BRAIN
- Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens
- (2011) Elaine A Sugarman et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Technical standards and guidelines for spinal muscular atrophy testing
- (2011) Thomas W Prior et al. GENETICS IN MEDICINE
- Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
- (2011) Adam K Bevan et al. MOLECULAR THERAPY
- Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits
- (2011) B. Akten et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Spinal muscular atrophy: a time for screening
- (2010) Thomas W Prior CURRENT OPINION IN PEDIATRICS
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- Impaired minor tri-snRNP assembly generates differential splicing defects of U12-type introns in lymphoblasts derived from a type I SMA patient
- (2010) Nawal Boulisfane et al. HUMAN MOLECULAR GENETICS
- Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
- (2010) Elisa Dominguez et al. HUMAN MOLECULAR GENETICS
- Early heart failure in the SMNΔ7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery
- (2010) Adam K. Bevan et al. HUMAN MOLECULAR GENETICS
- Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
- (2010) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
- (2010) C. F. Valori et al. Science Translational Medicine
- Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy
- (2009) J. H. Williams et al. JOURNAL OF NEUROSCIENCE
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
- (2009) Sandra Duque et al. MOLECULAR THERAPY
- Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
- (2009) Arthur H. M. Burghes et al. NATURE REVIEWS NEUROSCIENCE
- SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in Splicing
- (2008) Zhenxi Zhang et al. CELL
- An Assembly Chaperone Collaborates with the SMN Complex to Generate Spliceosomal SnRNPs
- (2008) Ashwin Chari et al. CELL
- Gene Therapy Using Adeno-Associated Virus Vectors
- (2008) S. Daya et al. CLINICAL MICROBIOLOGY REVIEWS
- Self-complementary AAV Vectors; Advances and Applications
- (2008) Douglas M McCarty MOLECULAR THERAPY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started